Oxcarbazepine Impurity 9 | CAS 59691-07-5 - Request Quote
Oxcarbazepine Impurity 9
| SZ CAT No: | SZ-O009027 |
| CAS No | 59691-07-5 |
| Mol.F. | C14H12BrN |
| Mol.Wt. | 274.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Oxcarbazepine Impurity 9 is chemically 10-Bromo-10,11-dihydro-5H-dibenzo[b,f]azepine. Oxcarbazepine Impurity 9 is supplied with detailed characterization data compliant with regulatory guideline. Oxcarbazepine Impurity 9 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oxcarbazepine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 59691-07-5
Purchase 59691-07-5
Order 59691-07-5
Enquire 59691-07-5
price of 59691-07-5
59691-07-5 Supplier
59691-07-5 Manufacturer
59691-07-5 Exporter
buy high quality Oxcarbazepine Impurity 9
Purchase Oxcarbazepine Impurity 9
Oxcarbazepine Impurity 9 suppliers
Oxcarbazepine Impurity 9 manufacturers
Oxcarbazepine Impurity 9 price
Order Oxcarbazepine Impurity 9
Enquire Oxcarbazepine Impurity 9
Oxcarbazepine Impurity 9 cost
Oxcarbazepine Impurity 9 Supplier
Oxcarbazepine Impurity 9 Distributor
Oxcarbazepine Impurity 9 for Method Validation
Oxcarbazepine Reference Standard
Oxcarbazepine Impurity 9 for ANDA Filing
Oxcarbazepine Impurity 9 for Forced Degradation Studies
Oxcarbazepine Impurity 9 Identification Standards
Oxcarbazepine Impurity 9 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


